Insight Molecular Diagnostics Inc. Cash Provided by (Used in) Operating Activities, Discontinued Operations
Insight Molecular Diagnostics Inc. (IMDX) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of -$4.36 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2024-05-15
- Insight Molecular Diagnostics Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2024-03-31 was -$4.36M.
- Insight Molecular Diagnostics Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2023-09-30 was $0.00.
- Insight Molecular Diagnostics Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2023-06-30 was $0.00.
- Insight Molecular Diagnostics Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2023-03-31 was -$4.36M.
- Insight Molecular Diagnostics Inc. cash provided by (used in) operating activities, discontinued operations for fiscal 2022 was -$20.79M.
- Insight Molecular Diagnostics Inc. cash provided by (used in) operating activities, discontinued operations for fiscal 2021 was -$13.64M.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month |
|---|---|---|---|---|
| 2024-03-31 | -$4.36M 10-Q · filed 2024-05-15 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | -$4.36M 10-Q · filed 2023-11-09 | -$9.40M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$4.36M 10-Q · filed 2023-08-10 | -$9.40M derived: sum of 3 quarters · filed 2023-08-10 | -$14.60M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-03-31 | -$4.36M 10-Q · filed 2023-05-15 | -$9.40M derived: sum of 2 quarters · filed 2023-05-15 | -$14.60M derived: sum of 3 quarters · filed 2023-11-09 | -$19.61M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-12-31 | -$5.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-12 | -$10.24M derived: sum of 2 quarters · filed 2023-11-09 | -$15.26M derived: sum of 3 quarters · filed 2023-11-09 | -$20.79M 10-K · filed 2023-04-12 |
| 2022-09-30 | -$5.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$10.21M derived: sum of 2 quarters · filed 2023-11-09 | -$15.74M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | -$5.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$10.55M 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | -$5.53M 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | -$13.64M 10-K · filed 2023-04-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |